1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
- --------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): January 25, 2001
Regeneron Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 333-31764 133444607
--------------- ------------ ------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
777 Old Saw Mill River Rd, Tarrytown NY, 10591-6707
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
9143477000
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
2
Regeneron Pharmaceuticals, Inc.
Current Report on Form 8-K
Items 1-4. Not applicable.
Item 5. Other Events.
On January 25, 2001, the Registrant issued a press release announcing
its operating results for the fourth quarter and year ended December 31, 2000.
The press release is attached hereto as Exhibit 99.1.
Item 6. Not Applicable.
Item 7. Financial Statements and Exhibits.
The following exhibits are furnished in accordance with the provisions
of Item 601 of Regulation S-K:
Exhibit No. Description
----------- -----------
99.1 Press Release, dated January 25, 2001
Item 8. Not Applicable
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned's duly authorized signatory.
Dated: January 25, 2001
REGENERON PHARMACEUTICALS, INC.
By: /s/ Murray A. Goldberg
----------------------------
Name: Murray A. Goldberg
Title: Vice President, Finance &
Administration, Chief Financial
Officer, Treasurer and
Assistant Secretary
3
4
EXHIBIT INDEX
Exhibit No. Description
- ----------- -----------
99.1 Press Release, dated January 25, 2001.
4